For example, in pancreatic cancer, KRAS promotes a shift in the glutamine pathway to support redox maintenance, as well as an increase in glycolysis to divert nutrients into the glycosylation and pentose phosphate pathways. This evidence concerns the gene KRAS and familial pancreatic carcinoma.